ABVX.PA
Abivax SA
Price:  
7.03 
EUR
Volume:  
73,681.00
France | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ABVX.PA Intrinsic Value

-297.59 %
Upside

What is the intrinsic value of ABVX.PA?

As of 2025-07-06, the Intrinsic Value of Abivax SA (ABVX.PA) is -13.89 EUR. This ABVX.PA valuation is based on the model Peter Lynch Fair Value. With the current market price of 7.03 EUR, the upside of Abivax SA is -297.59%.

Is ABVX.PA undervalued or overvalued?

Based on its market price of 7.03 EUR and our intrinsic valuation, Abivax SA (ABVX.PA) is overvalued by 297.59%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

7.03 EUR
Stock Price
-13.89 EUR
Intrinsic Value
Intrinsic Value Details

ABVX.PA Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -13.89 - -13.89 -13.89 -297.59%
P/E (18.50) - (15.95) (20.35) -389.5%
DDM - Stable (20.10) - (68.82) (44.46) -732.5%
DDM - Multi (15.80) - (44.30) (23.56) -435.1%

ABVX.PA Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 445.98
Beta 2.06
Outstanding shares (mil) 63.44
Enterprise Value (mil) 397.96
Market risk premium 5.82%
Cost of Equity 10.65%
Cost of Debt 5.00%
WACC 9.61%